Contact this trialFirst, we need to learn more about you.
Alkylating Agent
Acetazolamide + Temozolomide for Brain Cancer
Recruiting1 awardPhase 1
Chicago, Illinois
This trial tests a combination of two drugs, acetazolamide and temozolomide, in patients with a severe type of brain tumor. The goal is to see if this combination can improve treatment outcomes by attacking cancer cells and reducing brain pressure. Temozolomide is a drug with a good safety profile and has been effective in treating this type of brain tumor.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service